nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A1—Omeprazole—Barrett's esophagus	0.172	0.231	CbGbCtD
Pentamidine—CYP2C19—Esomeprazole—Barrett's esophagus	0.141	0.19	CbGbCtD
Pentamidine—CYP2C8—Omeprazole—Barrett's esophagus	0.0993	0.133	CbGbCtD
Pentamidine—CYP2C19—Omeprazole—Barrett's esophagus	0.0833	0.112	CbGbCtD
Pentamidine—CYP1A2—Omeprazole—Barrett's esophagus	0.0769	0.103	CbGbCtD
Pentamidine—CYP3A4—Esomeprazole—Barrett's esophagus	0.0684	0.0917	CbGbCtD
Pentamidine—CYP2D6—Omeprazole—Barrett's esophagus	0.0634	0.085	CbGbCtD
Pentamidine—CYP3A4—Omeprazole—Barrett's esophagus	0.0403	0.0541	CbGbCtD
Pentamidine—Oesophageal candidiasis—Esomeprazole—Barrett's esophagus	0.0101	0.0494	CcSEcCtD
Pentamidine—Oesophageal candidiasis—Omeprazole—Barrett's esophagus	0.0101	0.0494	CcSEcCtD
Pentamidine—Leg edema—Esomeprazole—Barrett's esophagus	0.00684	0.0335	CcSEcCtD
Pentamidine—Leg edema—Omeprazole—Barrett's esophagus	0.00684	0.0335	CcSEcCtD
Pentamidine—Tachypnoea—Esomeprazole—Barrett's esophagus	0.00539	0.0264	CcSEcCtD
Pentamidine—Tachypnoea—Omeprazole—Barrett's esophagus	0.00539	0.0264	CcSEcCtD
Pentamidine—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	0.0029	0.0142	CcSEcCtD
Pentamidine—Hypomagnesaemia—Omeprazole—Barrett's esophagus	0.0029	0.0142	CcSEcCtD
Pentamidine—Necrosis—Omeprazole—Barrett's esophagus	0.00235	0.0115	CcSEcCtD
Pentamidine—Necrosis—Esomeprazole—Barrett's esophagus	0.00235	0.0115	CcSEcCtD
Pentamidine—S100B—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—RELA—Barrett's esophagus	0.00234	0.046	CbGpPWpGaD
Pentamidine—Ageusia—Esomeprazole—Barrett's esophagus	0.00227	0.0111	CcSEcCtD
Pentamidine—Ageusia—Omeprazole—Barrett's esophagus	0.00227	0.0111	CcSEcCtD
Pentamidine—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00226	0.0444	CbGpPWpGaD
Pentamidine—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00226	0.0444	CbGpPWpGaD
Pentamidine—CYP4A11—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00219	0.0431	CbGpPWpGaD
Pentamidine—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00201	0.00986	CcSEcCtD
Pentamidine—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00201	0.00986	CcSEcCtD
Pentamidine—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00193	0.00948	CcSEcCtD
Pentamidine—Creatinine increased—Omeprazole—Barrett's esophagus	0.00193	0.00948	CcSEcCtD
Pentamidine—Melaena—Esomeprazole—Barrett's esophagus	0.0018	0.00882	CcSEcCtD
Pentamidine—Melaena—Omeprazole—Barrett's esophagus	0.0018	0.00882	CcSEcCtD
Pentamidine—Candida infection—Omeprazole—Barrett's esophagus	0.00176	0.00862	CcSEcCtD
Pentamidine—Candida infection—Esomeprazole—Barrett's esophagus	0.00176	0.00862	CcSEcCtD
Pentamidine—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00166	0.00816	CcSEcCtD
Pentamidine—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00166	0.00816	CcSEcCtD
Pentamidine—Lightheadedness—Esomeprazole—Barrett's esophagus	0.00165	0.00808	CcSEcCtD
Pentamidine—Lightheadedness—Omeprazole—Barrett's esophagus	0.00165	0.00808	CcSEcCtD
Pentamidine—S100B—RIP-mediated NFkB activation via ZBP1—RELA—Barrett's esophagus	0.00159	0.0313	CbGpPWpGaD
Pentamidine—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00153	0.0075	CcSEcCtD
Pentamidine—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00153	0.0075	CcSEcCtD
Pentamidine—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00143	0.0282	CbGpPWpGaD
Pentamidine—S100B—TRAF6 mediated NF-kB activation—RELA—Barrett's esophagus	0.00143	0.0282	CbGpPWpGaD
Pentamidine—CYP4A11—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00141	0.0278	CbGpPWpGaD
Pentamidine—Renal impairment—Omeprazole—Barrett's esophagus	0.0014	0.00689	CcSEcCtD
Pentamidine—Renal impairment—Esomeprazole—Barrett's esophagus	0.0014	0.00689	CcSEcCtD
Pentamidine—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00137	0.00672	CcSEcCtD
Pentamidine—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00137	0.00672	CcSEcCtD
Pentamidine—S100B—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RELA—Barrett's esophagus	0.00134	0.0264	CbGpPWpGaD
Pentamidine—S100B—ZBP1(DAI) mediated induction of type I IFNs—RELA—Barrett's esophagus	0.00134	0.0264	CbGpPWpGaD
Pentamidine—Face oedema—Esomeprazole—Barrett's esophagus	0.00129	0.00633	CcSEcCtD
Pentamidine—Face oedema—Omeprazole—Barrett's esophagus	0.00129	0.00633	CcSEcCtD
Pentamidine—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00125	0.00614	CcSEcCtD
Pentamidine—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00125	0.00614	CcSEcCtD
Pentamidine—Dry skin—Omeprazole—Barrett's esophagus	0.00123	0.00601	CcSEcCtD
Pentamidine—Dry skin—Esomeprazole—Barrett's esophagus	0.00123	0.00601	CcSEcCtD
Pentamidine—Gastritis—Esomeprazole—Barrett's esophagus	0.00118	0.0058	CcSEcCtD
Pentamidine—Gastritis—Omeprazole—Barrett's esophagus	0.00118	0.0058	CcSEcCtD
Pentamidine—CYP4A11—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00116	0.0229	CbGpPWpGaD
Pentamidine—Influenza—Omeprazole—Barrett's esophagus	0.00116	0.00566	CcSEcCtD
Pentamidine—Asthma—Omeprazole—Barrett's esophagus	0.00116	0.00566	CcSEcCtD
Pentamidine—Influenza—Esomeprazole—Barrett's esophagus	0.00116	0.00566	CcSEcCtD
Pentamidine—Asthma—Esomeprazole—Barrett's esophagus	0.00116	0.00566	CcSEcCtD
Pentamidine—Bronchospasm—Omeprazole—Barrett's esophagus	0.00114	0.00557	CcSEcCtD
Pentamidine—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00114	0.00557	CcSEcCtD
Pentamidine—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00113	0.00555	CcSEcCtD
Pentamidine—Pancreatitis—Omeprazole—Barrett's esophagus	0.00113	0.00555	CcSEcCtD
Pentamidine—Pancytopenia—Esomeprazole—Barrett's esophagus	0.0011	0.00538	CcSEcCtD
Pentamidine—Pancytopenia—Omeprazole—Barrett's esophagus	0.0011	0.00538	CcSEcCtD
Pentamidine—Neutropenia—Esomeprazole—Barrett's esophagus	0.00108	0.0053	CcSEcCtD
Pentamidine—Neutropenia—Omeprazole—Barrett's esophagus	0.00108	0.0053	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00102	0.00501	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00102	0.00501	CcSEcCtD
Pentamidine—Renal failure—Omeprazole—Barrett's esophagus	0.00101	0.00496	CcSEcCtD
Pentamidine—Renal failure—Esomeprazole—Barrett's esophagus	0.00101	0.00496	CcSEcCtD
Pentamidine—Stomatitis—Esomeprazole—Barrett's esophagus	0.001	0.00492	CcSEcCtD
Pentamidine—Stomatitis—Omeprazole—Barrett's esophagus	0.001	0.00492	CcSEcCtD
Pentamidine—Conjunctivitis—Omeprazole—Barrett's esophagus	0.001	0.00491	CcSEcCtD
Pentamidine—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.001	0.00491	CcSEcCtD
Pentamidine—Haematuria—Esomeprazole—Barrett's esophagus	0.000982	0.00482	CcSEcCtD
Pentamidine—Haematuria—Omeprazole—Barrett's esophagus	0.000982	0.00482	CcSEcCtD
Pentamidine—Sinusitis—Esomeprazole—Barrett's esophagus	0.000966	0.00474	CcSEcCtD
Pentamidine—Sinusitis—Omeprazole—Barrett's esophagus	0.000966	0.00474	CcSEcCtD
Pentamidine—Bradycardia—Esomeprazole—Barrett's esophagus	0.000941	0.00462	CcSEcCtD
Pentamidine—Bradycardia—Omeprazole—Barrett's esophagus	0.000941	0.00462	CcSEcCtD
Pentamidine—Rhinitis—Esomeprazole—Barrett's esophagus	0.000927	0.00455	CcSEcCtD
Pentamidine—Rhinitis—Omeprazole—Barrett's esophagus	0.000927	0.00455	CcSEcCtD
Pentamidine—Hepatitis—Esomeprazole—Barrett's esophagus	0.000925	0.00453	CcSEcCtD
Pentamidine—Hepatitis—Omeprazole—Barrett's esophagus	0.000925	0.00453	CcSEcCtD
Pentamidine—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00092	0.00451	CcSEcCtD
Pentamidine—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00092	0.00451	CcSEcCtD
Pentamidine—Hallucination—Omeprazole—Barrett's esophagus	0.00092	0.00451	CcSEcCtD
Pentamidine—Hallucination—Esomeprazole—Barrett's esophagus	0.00092	0.00451	CcSEcCtD
Pentamidine—Pharyngitis—Omeprazole—Barrett's esophagus	0.000918	0.0045	CcSEcCtD
Pentamidine—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000918	0.0045	CcSEcCtD
Pentamidine—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000911	0.00447	CcSEcCtD
Pentamidine—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000911	0.00447	CcSEcCtD
Pentamidine—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000874	0.00429	CcSEcCtD
Pentamidine—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000874	0.00429	CcSEcCtD
Pentamidine—CYP1A1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000868	0.0171	CbGpPWpGaD
Pentamidine—Flushing—Esomeprazole—Barrett's esophagus	0.000858	0.00421	CcSEcCtD
Pentamidine—Flushing—Omeprazole—Barrett's esophagus	0.000858	0.00421	CcSEcCtD
Pentamidine—Chills—Omeprazole—Barrett's esophagus	0.00083	0.00407	CcSEcCtD
Pentamidine—Chills—Esomeprazole—Barrett's esophagus	0.00083	0.00407	CcSEcCtD
Pentamidine—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000796	0.0157	CbGpPWpGaD
Pentamidine—Tension—Esomeprazole—Barrett's esophagus	0.00079	0.00387	CcSEcCtD
Pentamidine—Tension—Omeprazole—Barrett's esophagus	0.00079	0.00387	CcSEcCtD
Pentamidine—Dysgeusia—Omeprazole—Barrett's esophagus	0.000788	0.00386	CcSEcCtD
Pentamidine—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000788	0.00386	CcSEcCtD
Pentamidine—Nervousness—Omeprazole—Barrett's esophagus	0.000782	0.00383	CcSEcCtD
Pentamidine—Nervousness—Esomeprazole—Barrett's esophagus	0.000782	0.00383	CcSEcCtD
Pentamidine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000768	0.0151	CbGpPWpGaD
Pentamidine—Vision blurred—Esomeprazole—Barrett's esophagus	0.000759	0.00372	CcSEcCtD
Pentamidine—Vision blurred—Omeprazole—Barrett's esophagus	0.000759	0.00372	CcSEcCtD
Pentamidine—Tremor—Esomeprazole—Barrett's esophagus	0.000754	0.0037	CcSEcCtD
Pentamidine—Tremor—Omeprazole—Barrett's esophagus	0.000754	0.0037	CcSEcCtD
Pentamidine—Anaemia—Esomeprazole—Barrett's esophagus	0.000744	0.00365	CcSEcCtD
Pentamidine—Anaemia—Omeprazole—Barrett's esophagus	0.000744	0.00365	CcSEcCtD
Pentamidine—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000743	0.0146	CbGpPWpGaD
Pentamidine—Angioedema—Esomeprazole—Barrett's esophagus	0.000736	0.00361	CcSEcCtD
Pentamidine—Angioedema—Omeprazole—Barrett's esophagus	0.000736	0.00361	CcSEcCtD
Pentamidine—Vertigo—Esomeprazole—Barrett's esophagus	0.000723	0.00355	CcSEcCtD
Pentamidine—Vertigo—Omeprazole—Barrett's esophagus	0.000723	0.00355	CcSEcCtD
Pentamidine—Leukopenia—Omeprazole—Barrett's esophagus	0.000721	0.00353	CcSEcCtD
Pentamidine—Leukopenia—Esomeprazole—Barrett's esophagus	0.000721	0.00353	CcSEcCtD
Pentamidine—Palpitations—Omeprazole—Barrett's esophagus	0.000711	0.00349	CcSEcCtD
Pentamidine—Palpitations—Esomeprazole—Barrett's esophagus	0.000711	0.00349	CcSEcCtD
Pentamidine—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000711	0.014	CbGpPWpGaD
Pentamidine—Cough—Omeprazole—Barrett's esophagus	0.000702	0.00344	CcSEcCtD
Pentamidine—Cough—Esomeprazole—Barrett's esophagus	0.000702	0.00344	CcSEcCtD
Pentamidine—Hypertension—Omeprazole—Barrett's esophagus	0.000695	0.00341	CcSEcCtD
Pentamidine—Hypertension—Esomeprazole—Barrett's esophagus	0.000695	0.00341	CcSEcCtD
Pentamidine—Myalgia—Omeprazole—Barrett's esophagus	0.000685	0.00336	CcSEcCtD
Pentamidine—Chest pain—Esomeprazole—Barrett's esophagus	0.000685	0.00336	CcSEcCtD
Pentamidine—Myalgia—Esomeprazole—Barrett's esophagus	0.000685	0.00336	CcSEcCtD
Pentamidine—Chest pain—Omeprazole—Barrett's esophagus	0.000685	0.00336	CcSEcCtD
Pentamidine—Arthralgia—Esomeprazole—Barrett's esophagus	0.000685	0.00336	CcSEcCtD
Pentamidine—Arthralgia—Omeprazole—Barrett's esophagus	0.000685	0.00336	CcSEcCtD
Pentamidine—Anxiety—Omeprazole—Barrett's esophagus	0.000683	0.00335	CcSEcCtD
Pentamidine—Anxiety—Esomeprazole—Barrett's esophagus	0.000683	0.00335	CcSEcCtD
Pentamidine—Discomfort—Omeprazole—Barrett's esophagus	0.000677	0.00332	CcSEcCtD
Pentamidine—Discomfort—Esomeprazole—Barrett's esophagus	0.000677	0.00332	CcSEcCtD
Pentamidine—Dry mouth—Omeprazole—Barrett's esophagus	0.00067	0.00329	CcSEcCtD
Pentamidine—Dry mouth—Esomeprazole—Barrett's esophagus	0.00067	0.00329	CcSEcCtD
Pentamidine—Confusional state—Omeprazole—Barrett's esophagus	0.000662	0.00325	CcSEcCtD
Pentamidine—Confusional state—Esomeprazole—Barrett's esophagus	0.000662	0.00325	CcSEcCtD
Pentamidine—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000657	0.0129	CbGpPWpGaD
Pentamidine—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000657	0.00322	CcSEcCtD
Pentamidine—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000657	0.00322	CcSEcCtD
Pentamidine—Infection—Omeprazole—Barrett's esophagus	0.000653	0.0032	CcSEcCtD
Pentamidine—Infection—Esomeprazole—Barrett's esophagus	0.000653	0.0032	CcSEcCtD
Pentamidine—Shock—Esomeprazole—Barrett's esophagus	0.000646	0.00317	CcSEcCtD
Pentamidine—Shock—Omeprazole—Barrett's esophagus	0.000646	0.00317	CcSEcCtD
Pentamidine—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000643	0.00315	CcSEcCtD
Pentamidine—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000643	0.00315	CcSEcCtD
Pentamidine—Tachycardia—Esomeprazole—Barrett's esophagus	0.000641	0.00314	CcSEcCtD
Pentamidine—Tachycardia—Omeprazole—Barrett's esophagus	0.000641	0.00314	CcSEcCtD
Pentamidine—S100B—Cytosolic sensors of pathogen-associated DNA—RELA—Barrett's esophagus	0.000637	0.0125	CbGpPWpGaD
Pentamidine—Anorexia—Omeprazole—Barrett's esophagus	0.000626	0.00307	CcSEcCtD
Pentamidine—Anorexia—Esomeprazole—Barrett's esophagus	0.000626	0.00307	CcSEcCtD
Pentamidine—CYP4A11—Biological oxidations—CYP26A1—Barrett's esophagus	0.000617	0.0121	CbGpPWpGaD
Pentamidine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000602	0.0118	CbGpPWpGaD
Pentamidine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000599	0.00293	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000599	0.00293	CcSEcCtD
Pentamidine—Insomnia—Esomeprazole—Barrett's esophagus	0.000594	0.00291	CcSEcCtD
Pentamidine—Insomnia—Omeprazole—Barrett's esophagus	0.000594	0.00291	CcSEcCtD
Pentamidine—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000594	0.0117	CbGpPWpGaD
Pentamidine—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00059	0.00289	CcSEcCtD
Pentamidine—Paraesthesia—Omeprazole—Barrett's esophagus	0.00059	0.00289	CcSEcCtD
Pentamidine—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000586	0.00287	CcSEcCtD
Pentamidine—Dyspnoea—Omeprazole—Barrett's esophagus	0.000586	0.00287	CcSEcCtD
Pentamidine—Somnolence—Esomeprazole—Barrett's esophagus	0.000584	0.00286	CcSEcCtD
Pentamidine—Somnolence—Omeprazole—Barrett's esophagus	0.000584	0.00286	CcSEcCtD
Pentamidine—Dyspepsia—Omeprazole—Barrett's esophagus	0.000578	0.00284	CcSEcCtD
Pentamidine—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000578	0.00284	CcSEcCtD
Pentamidine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000575	0.0113	CbGpPWpGaD
Pentamidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000571	0.0112	CbGpPWpGaD
Pentamidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000571	0.0112	CbGpPWpGaD
Pentamidine—Decreased appetite—Omeprazole—Barrett's esophagus	0.000571	0.0028	CcSEcCtD
Pentamidine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000571	0.0028	CcSEcCtD
Pentamidine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000569	0.0112	CbGpPWpGaD
Pentamidine—Fatigue—Esomeprazole—Barrett's esophagus	0.000566	0.00278	CcSEcCtD
Pentamidine—Fatigue—Omeprazole—Barrett's esophagus	0.000566	0.00278	CcSEcCtD
Pentamidine—Pain—Omeprazole—Barrett's esophagus	0.000562	0.00275	CcSEcCtD
Pentamidine—Constipation—Esomeprazole—Barrett's esophagus	0.000562	0.00275	CcSEcCtD
Pentamidine—Pain—Esomeprazole—Barrett's esophagus	0.000562	0.00275	CcSEcCtD
Pentamidine—Constipation—Omeprazole—Barrett's esophagus	0.000562	0.00275	CcSEcCtD
Pentamidine—CYP1A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000561	0.011	CbGpPWpGaD
Pentamidine—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000554	0.0109	CbGpPWpGaD
Pentamidine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—RELA—Barrett's esophagus	0.000546	0.0107	CbGpPWpGaD
Pentamidine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000541	0.00265	CcSEcCtD
Pentamidine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000541	0.00265	CcSEcCtD
Pentamidine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000537	0.00263	CcSEcCtD
Pentamidine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000537	0.00263	CcSEcCtD
Pentamidine—Urticaria—Esomeprazole—Barrett's esophagus	0.000522	0.00256	CcSEcCtD
Pentamidine—Urticaria—Omeprazole—Barrett's esophagus	0.000522	0.00256	CcSEcCtD
Pentamidine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000521	0.0103	CbGpPWpGaD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.00052	0.0102	CbGpPWpGaD
Pentamidine—Body temperature increased—Omeprazole—Barrett's esophagus	0.000519	0.00255	CcSEcCtD
Pentamidine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000519	0.00255	CcSEcCtD
Pentamidine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000519	0.00255	CcSEcCtD
Pentamidine—Abdominal pain—Omeprazole—Barrett's esophagus	0.000519	0.00255	CcSEcCtD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000515	0.0101	CbGpPWpGaD
Pentamidine—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000515	0.0101	CbGpPWpGaD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000506	0.00996	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000488	0.00961	CbGpPWpGaD
Pentamidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000488	0.0096	CbGpPWpGaD
Pentamidine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000484	0.00237	CcSEcCtD
Pentamidine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000484	0.00237	CcSEcCtD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.00048	0.00944	CbGpPWpGaD
Pentamidine—Asthenia—Omeprazole—Barrett's esophagus	0.000471	0.00231	CcSEcCtD
Pentamidine—Asthenia—Esomeprazole—Barrett's esophagus	0.000471	0.00231	CcSEcCtD
Pentamidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000465	0.00916	CbGpPWpGaD
Pentamidine—Pruritus—Esomeprazole—Barrett's esophagus	0.000465	0.00228	CcSEcCtD
Pentamidine—Pruritus—Omeprazole—Barrett's esophagus	0.000465	0.00228	CcSEcCtD
Pentamidine—CYP1A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000461	0.00907	CbGpPWpGaD
Pentamidine—S100B—MyD88-independent cascade—RELA—Barrett's esophagus	0.00046	0.00906	CbGpPWpGaD
Pentamidine—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000459	0.00904	CbGpPWpGaD
Pentamidine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000449	0.0022	CcSEcCtD
Pentamidine—Diarrhoea—Omeprazole—Barrett's esophagus	0.000449	0.0022	CcSEcCtD
Pentamidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000441	0.00868	CbGpPWpGaD
Pentamidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000441	0.00868	CbGpPWpGaD
Pentamidine—Dizziness—Omeprazole—Barrett's esophagus	0.000434	0.00213	CcSEcCtD
Pentamidine—Dizziness—Esomeprazole—Barrett's esophagus	0.000434	0.00213	CcSEcCtD
Pentamidine—CYP4A11—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000429	0.00845	CbGpPWpGaD
Pentamidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000428	0.00842	CbGpPWpGaD
Pentamidine—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000423	0.00832	CbGpPWpGaD
Pentamidine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000422	0.00831	CbGpPWpGaD
Pentamidine—Vomiting—Omeprazole—Barrett's esophagus	0.000418	0.00205	CcSEcCtD
Pentamidine—Vomiting—Esomeprazole—Barrett's esophagus	0.000418	0.00205	CcSEcCtD
Pentamidine—Rash—Omeprazole—Barrett's esophagus	0.000414	0.00203	CcSEcCtD
Pentamidine—Rash—Esomeprazole—Barrett's esophagus	0.000414	0.00203	CcSEcCtD
Pentamidine—S100B—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000414	0.00815	CbGpPWpGaD
Pentamidine—Dermatitis—Esomeprazole—Barrett's esophagus	0.000414	0.00203	CcSEcCtD
Pentamidine—Dermatitis—Omeprazole—Barrett's esophagus	0.000414	0.00203	CcSEcCtD
Pentamidine—Headache—Omeprazole—Barrett's esophagus	0.000412	0.00202	CcSEcCtD
Pentamidine—Headache—Esomeprazole—Barrett's esophagus	0.000412	0.00202	CcSEcCtD
Pentamidine—Nausea—Esomeprazole—Barrett's esophagus	0.00039	0.00191	CcSEcCtD
Pentamidine—Nausea—Omeprazole—Barrett's esophagus	0.00039	0.00191	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.00039	0.00767	CbGpPWpGaD
Pentamidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000377	0.00742	CbGpPWpGaD
Pentamidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000363	0.00714	CbGpPWpGaD
Pentamidine—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000358	0.00704	CbGpPWpGaD
Pentamidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000347	0.00683	CbGpPWpGaD
Pentamidine—S100B—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000347	0.00683	CbGpPWpGaD
Pentamidine—CYP4A11—NRF2 pathway—HGF—Barrett's esophagus	0.000323	0.00636	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000313	0.00615	CbGpPWpGaD
Pentamidine—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000306	0.00602	CbGpPWpGaD
Pentamidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000294	0.00579	CbGpPWpGaD
Pentamidine—CYP4A11—PPARA activates gene expression—PPARG—Barrett's esophagus	0.00029	0.00571	CbGpPWpGaD
Pentamidine—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000284	0.00559	CbGpPWpGaD
Pentamidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00028	0.00551	CbGpPWpGaD
Pentamidine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000276	0.00544	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000259	0.0051	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000256	0.00503	CbGpPWpGaD
Pentamidine—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000245	0.00482	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000242	0.00475	CbGpPWpGaD
Pentamidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000227	0.00446	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000225	0.00442	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000221	0.00436	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.0002	0.00394	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000198	0.00389	CbGpPWpGaD
Pentamidine—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000196	0.00385	CbGpPWpGaD
Pentamidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000188	0.0037	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000187	0.00369	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000184	0.00363	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000182	0.00358	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000182	0.00358	CbGpPWpGaD
Pentamidine—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00017	0.00335	CbGpPWpGaD
Pentamidine—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000156	0.00307	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000156	0.00307	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000154	0.00303	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—GAST—Barrett's esophagus	0.000149	0.00294	CbGpPWpGaD
Pentamidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000145	0.00285	CbGpPWpGaD
Pentamidine—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000139	0.00274	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGES—Barrett's esophagus	0.000139	0.00274	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000124	0.00244	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000121	0.00237	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000119	0.00235	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000119	0.00234	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000116	0.00228	CbGpPWpGaD
Pentamidine—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000115	0.00227	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000114	0.00224	CbGpPWpGaD
Pentamidine—S100B—Immune System—HGF—Barrett's esophagus	0.000113	0.00222	CbGpPWpGaD
Pentamidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000113	0.00222	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—RELA—Barrett's esophagus	0.000112	0.00221	CbGpPWpGaD
Pentamidine—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000109	0.00214	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP26A1—Barrett's esophagus	0.000106	0.00208	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SST—Barrett's esophagus	0.000102	0.00201	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000102	0.002	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.91e-05	0.00156	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	7.8e-05	0.00153	CbGpPWpGaD
Pentamidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	7.77e-05	0.00153	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—SLC9A1—Barrett's esophagus	7.61e-05	0.0015	CbGpPWpGaD
Pentamidine—S100B—Immune System—RELA—Barrett's esophagus	6.55e-05	0.00129	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	6.13e-05	0.00121	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGES—Barrett's esophagus	5.85e-05	0.00115	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGES—Barrett's esophagus	5.53e-05	0.00109	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—APC—Barrett's esophagus	5.42e-05	0.00107	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGES—Barrett's esophagus	5.07e-05	0.000997	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGES—Barrett's esophagus	4.52e-05	0.00089	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	4.43e-05	0.000872	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—RELA—Barrett's esophagus	4.23e-05	0.000833	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	4.19e-05	0.000824	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGES—Barrett's esophagus	4.16e-05	0.000819	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL8—Barrett's esophagus	3.99e-05	0.000785	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	3.84e-05	0.000756	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGES—Barrett's esophagus	3.52e-05	0.000693	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PPARG—Barrett's esophagus	3.47e-05	0.000683	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	3.43e-05	0.000674	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	3.2e-05	0.000629	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	3.15e-05	0.00062	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.09e-05	0.000609	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	3.02e-05	0.000594	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.84e-05	0.000558	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	2.77e-05	0.000545	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—Barrett's esophagus	2.73e-05	0.000538	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.72e-05	0.000535	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	2.67e-05	0.000526	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.53e-05	0.000498	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	2.47e-05	0.000486	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—Barrett's esophagus	2.45e-05	0.000482	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.43e-05	0.000479	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.27e-05	0.000447	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.23e-05	0.000439	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.06e-05	0.000406	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.99e-05	0.000392	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.97e-05	0.000388	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.92e-05	0.000379	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.55e-05	0.000305	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.49e-05	0.000292	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.46e-05	0.000287	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARG—Barrett's esophagus	1.38e-05	0.000271	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.26e-05	0.000249	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	1.15e-05	0.000226	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARG—Barrett's esophagus	1.13e-05	0.000222	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	1.08e-05	0.000213	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.04e-05	0.000204	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	9.94e-06	0.000196	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	8.87e-06	0.000175	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARG—Barrett's esophagus	8.79e-06	0.000173	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	8.16e-06	0.000161	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	6.91e-06	0.000136	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARG—Barrett's esophagus	6.78e-06	0.000133	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	5.33e-06	0.000105	CbGpPWpGaD
